diabetes market

Top Reports

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises analytical insights across various innovations. The TOE describes disruptive technological developments across stem cell platforms, personalized medicine, use of artificial intelligence for Alzheimer’s disease, gene therapies, melanoma management, biomarkers, vaccin...

USD 950.00

The Life Science, Health & Wellness TOE depicts the current landscape and the new life sciences trends across twelve groundbreaking drug discovery and genetic platforms. Each and every platform is accurately profiled covering the most cutting-edge technologies energizing the pharmaceutical landscape, such as quantum computing in life sciences, inno...

USD 950.00

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across diabetes care, CAR-T cell therapy, pedriatic and genetic disease treatment. Novel solutions for pancreatic islet transplants, CAR-T cell therapy, enzyme replacement therapy, and autism correlations are profiled. Clinical trials scenario for Alzheimer's disease is also...

USD 250.00

USD 225.00 save 10 %

This edition of the Inside R&D TechVision Opportunity Engine (TOE) depicts developments associated with laser light in dental treatment, rare earth element recovery, and diabetes treatment. The TOE also focuses on advancements in syngas-based fuel production from coal and AI-based traffic management solution. Inside R&D TechVision Opportunity Engi...

USD 250.00

USD 212.50 save 15 %

31 Mar 2017  |  North America

Future of Diabetes Care Paradigms, Forecast to 2022

Innovations to Disrupt Diabetes Wellness, Diagnosis, Monitoring, and Therapy

Diabetes management is on the verge of being disrupted by innovative technologies such as artificial pancreas, non-invasive glucose monitoring sensors, wearables, apps, and inhalable insulin. This research study captures all the innovative developments across the segments of wellness, diagnosis, monitoring, and therapy of the diabetes care continuu...

USD 4,950.00

USD 3,712.50 save 25 %

02 Mar 2017  |  Global

Biomarkers Enabling Diabetes and Obesity Management

Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management

Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...

USD 4,950.00

USD 3,712.50 save 25 %

This edition of Genetic TOE profiles life sciences trends across diabetes and obesity management. The corresponding patent scenario is depicted along with the industry interactions. The Genetic TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of...

USD 250.00

USD 187.50 save 25 %

This edition of Inside R&D TOE depicts innovations in medicine by improving diabetes treatment and cancer diagnostics, as well as, sustainability through energy storage, solar cells and waste management. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas....

USD 1,500.00

USD 1,125.00 save 25 %

This edition of the Inside R&D TOE depicts Innovations in air conditioners, diabetes testing, touch sensing technologies, and therapies for liver diseases. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovati...

USD 250.00

USD 187.50 save 25 %

30 Mar 2016  |  Global

Next Generation Diabetes Therapy and Drug Delivery Technologies

Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory

Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...

USD 4,950.00

USD 3,712.50 save 25 %